Updated
Updated · The New York Times · Nov 16
John H. Powers III Takes Over $6.5 Billion NIAID as Trump-Era Upheaval Deepens
Updated
Updated · The New York Times · Nov 16

John H. Powers III Takes Over $6.5 Billion NIAID as Trump-Era Upheaval Deepens

3 articles · Updated · The New York Times · Nov 16

Summary

  • John H. Powers III was appointed Monday to run NIAID, putting an infectious-disease trial specialist in charge of the NIH’s $6.5 billion institute for threats including measles and Ebola.
  • Powers’ rise accelerated under the second Trump administration as he worked on vaccine-injury research championed by Health Secretary Robert F. Kennedy Jr., though he said Monday that vaccines and autism are a policy question outside his remit.
  • NIH said Powers ultimately did no work on CDC vaccine-autism data that emails showed had been sought by NIH leaders, while supporters describe him as attentive to rare vaccine harms and colleagues say he has tried to keep such studies scientific.
  • The appointment lands amid deep disruption at the institute: Fauci successor Jeanne Marrazzo was fired, acting chief Jeffery Taubenberger was pushed aside, investigators have sought records from infectious-disease scientists, and several major research networks still await renewed funding.

Insights

How will Dr. Powers' focus on vaccine safety reshape NIAID's $6.5 billion strategy for future global outbreak preparedness?
What impact will the delayed funding for key HIV research networks have under the new NIAID leadership?
Can a new federal vaccine-injury initiative improve public trust without compromising decades of infectious disease research progress?